alexa Laser-based Vaccine Adjuvant And Delivery
ISSN: 2157-7560

Journal of Vaccines & Vaccination
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

3rd International Conference on Vaccines & Vaccination
July 29-31, 2013 Embassy Suites Las Vegas, NV, USA

Mei X. Wu, Ji Wang, Xinyuan Chen, Dilip K. Shah and Richard R. Anderson
Accepted Abstracts: J Vaccines Vaccin
DOI: 10.4172/2157-7560.S1.018
Abstract
W e develop a safe, laser-based adjuvant for cutaneous vaccination, which can be used immediately and unlimitedly at any time, irrespective of skin colors, for existing and new protein-based vaccines. The tentative laser apparatus is FDA approved for home cosmetics. It is as small as a hand-held flashlight and extremely safe and convenient to use. Our investigation showed that illumination of the injection site for 10 ms prior to intradermal (ID) vaccination could enhance immune responses significantly against the vaccine. When imiquimod (ImiQ or ALDARA 5%), an agonist for Toll-like receptor (TLR7) that is also FDA approved for topical application in humans, was topically applied to the site of injection, laser illumination and ImiQ synergistically increased Th1 immune responses. The laser generates an array of microscopic thermal zones (MTZs) that are each about 100~300 μm in diameter and 300- 1,000 μm in depth in the skin. The dead cells in MTZs release ?danger signals? that attract and activate a huge number of antigen presenting cells (APCs) around each MTZ. These APCs not only clean the dead cells in the MTZs but also take-up and process antigens ID injected. Because the APCs are concentrated around each MTZ, the resultant inflammation is microscopically restricted and hardly visible in the skin. Moreover, each MTZ is surrounded by healthy growing epidermal cells that migrate and grow quickly toward the MTZ and completely heal the micro-zone in a day or two. As a result, skin reactogenicity was significantly diminished in terms of severity and duration with laser-ImiQ adjuvant as compared to that caused by the vaccine alone. For instance, we found that pre-illumination of the injection site augmented hemagglutination inhibition (HAI) titers against seasonal or 2009-pandemic influenza vaccine by 10~20-folds over intramuscular (IM) immunization, but the resultant skin irritation was milder and resolved faster than flu vaccine alone. While ID immunization blocked viral production in the lung by 2-fold over IM vaccination, ID immunization with laser-ImiQ adjuvant resulted in a blockade of viral production by more than 100-fold. Conclusion: Many current vaccine adjuvants cause significant skin irritation and are prohibited from skin vaccination. Laser- based adjuvant is able to boost cutaneous vaccination without increasing adverse effects or an involvement of injecting any additives besides antigen itself. It holds great promise to safely boost cutaneous vaccination with a short- and long-term safety profile.
Biography
Mei X. Wu is an Associate Professor in the Department of Dermatology at Harvard Medical School (HMS) and an affiliated faculty of the Harvard- MIT Division of Health Sciences and Technology. She received her Ph.D. from Utah State University in 1992 and was then trained at Massachusetts Institute of Technology and HMS. She has more than 50 publications in peer-reviewed journals and her research has been continuously supported by various competitive funds from National Institutes of Health (NIH), Department of Defense, the American Cancer Society, the Crohn?s & Colitis Foundation of America, the American Heart Association, and Bill Gates Foundation.
image PDF   |   image HTML
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version